PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.00%
Positive revenue growth while 2127.T is negative. John Neff might see a notable competitive edge here.
3.45%
Positive gross profit growth while 2127.T is negative. John Neff would see a clear operational edge over the competitor.
-12.72%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-11.49%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
44.66%
Positive net income growth while 2127.T is negative. John Neff might see a big relative performance advantage.
44.66%
Positive EPS growth while 2127.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
44.66%
Positive diluted EPS growth while 2127.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
36.07%
10Y revenue/share CAGR under 50% of 2127.T's 255.94%. Michael Burry would suspect a lasting competitive disadvantage.
-13.38%
Negative 5Y CAGR while 2127.T stands at 154.24%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
32.50%
3Y revenue/share CAGR at 75-90% of 2127.T's 39.27%. Bill Ackman would expect new product strategies to close the gap.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
141.27%
Below 50% of 2127.T's 284.05%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
37.60%
Below 50% of 2127.T's 108.38%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
124.28%
Positive short-term CAGR while 2127.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
132.72%
10Y equity/share CAGR at 50-75% of 2127.T's 253.21%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
27.89%
Below 50% of 2127.T's 133.62%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
71.06%
3Y equity/share CAGR 1.25-1.5x 2127.T's 48.52%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-25.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
2.27%
Below 50% of 2127.T's 320.00%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
-25.00%
Negative near-term dividend growth while 2127.T invests at 75.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-37.14%
Firm’s AR is declining while 2127.T shows 0.50%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
3.40%
Inventory shrinking or stable vs. 2127.T's 24.51%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
8.47%
Asset growth above 1.5x 2127.T's 4.70%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
6.41%
Similar to 2127.T's 6.28%. Walter Schloss finds parallel capital usage or profit distribution strategies.
25.46%
We have some new debt while 2127.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-42.69%
We cut SG&A while 2127.T invests at 13.28%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.